期刊文献+

乳腺癌术后辅助化疗演变及进展 被引量:1

原文传递
导出
摘要 乳腺癌是临床上最常见的女性恶性肿瘤之一,我国女性乳腺癌的发病率逐年提高,在北京、上海等发达城市,乳腺癌已成为年轻女性的第一位死亡原因。乳腺癌的发病率呈不断上升的趋势,但随着诊断技术进步及乳腺癌研究的不断深入,乳腺癌得以早期发现,且治疗变得更加有效,因此乳腺癌的死亡率正呈现出下降的趋势。
出处 《临床外科杂志》 2011年第7期443-446,共4页 Journal of Clinical Surgery
  • 相关文献

参考文献37

  • 1Bear HD. Measuring circulating tumor ceils as a surrogate end point for adjuvant therapy of breast cancer:what do they mean and what should we do about them [J] ? J Clin Oncol,2008,26(8) :1195-1197.
  • 2Valagussa P, Bonadonna G, Veronesi U. Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients [ J ]. Cancer,1978,41 (3) :1170-1178.
  • 3Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adju- vant therapy on mortality from breast cancer[ J ]. N Engl J Ned, 2005, 353(17) :1784-1792.
  • 4Early Breast Cancer Trialist'Collaboration Group. Effects of chemothera- py and homonal therapy for breast cancer on recurrent and 15 - years survial : an overview of the mndomised trials [ J ]. Lancet, 2005,365 (9503) : 1687-1717.
  • 5Fossati R,Confalonieri C, Torri V, et al. Cytotoxic and hormonal treat- ment for metastatic breast cancer:a systematic review of published ran- domized trials involving 31, 510 women [ J ]. J Clin Oncol, 1998, 16 (10) :3439-3460.
  • 6Cochrane Database System Reviews. [ http://www2. cochrane. org/re-views/en/subtopics/52. html ].
  • 7Bonadonna G, M oliterni A, Zambetti M, et al. 30 years follow up of ran- domized studies of adjuvant CMF in operable breast cancer:cohort study [J]. BMJ,2005,330( 15 ) :217-220.
  • 8Early Breast Cancer Trialists' Collaborative Group. Effects of chemo- therapy and hormonal therapy for early breast cancer on recurrence and 15- year survival: an overview of the randomized trials [ J]. Lancet , 2005,365(8) :1687-1717.
  • 9Fisher B, Anderson S, Tan - Chiu E, et al. Tamoxifen and chemotherapy for axillary node - negative, estrogen receptor - negative breast cancer : findings from National Surgical Adjuvant Breast and Bowel Project B - 23 [ J ]. J Clin Oncol,2001,19 (4) :931-942.
  • 10Fisher B, Brown AM, Dimitrov NV, et al. Two months of doxorubicin - cyclophosphamide with and without interval reinduction therapy com- pared with 6 months of cyclophosphamide, methotrexate, and fluoroura- cil in positive - node breast cancer patients with tamoxifen - nonre- sponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B- 15[J]. J Clin Oncol,1990,8(9) :1483-1496.

同被引文献19

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部